Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Patenting antibodies in Europe.

Literature DB >> 20073135

Patenting antibodies in Europe.

Louise Holliday¹.

Abstract

Mesh：

Substances：
Antibodies

Year: 2009 PMID： 20073135 PMCID： PMC2726612 DOI： 10.4161/mabs.1.4.8802

Source DB: PubMed Journal: MAbs ISSN： 1942-0862 Impact factor: 5.857

Keyword Cloud
Cited

× No keyword cloud information.

3 in total

1. European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK.

Authors: Janice M Reichert; Alain Beck; Harish Iyer
Journal: MAbs Date: 2009-09-25 Impact factor: 5.857

2. 5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.

Authors: Alain Beck; Janice M Reichert; Thierry Wurch
Journal: MAbs Date: 2010 Mar-Apr Impact factor: 5.857

3. The N14 anti-afamin antibody Fab: a rare V_L1 CDR glycosylation, crystallographic re-sequencing, molecular plasticity and conservative versus enthusiastic modelling.

Authors: Andreas Naschberger; Barbara G Fürnrohr; Tihana Lenac Rovis; Suzana Malic; Klaus Scheffzek; Hans Dieplinger; Bernhard Rupp
Journal: Acta Crystallogr D Struct Biol Date: 2016-11-29 Impact factor: 7.652

3 in total

Patenting antibodies in Europe.

1. European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK.

2. 5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.

3. The N14 anti-afamin antibody Fab: a rare VL1 CDR glycosylation, crystallographic re-sequencing, molecular plasticity and conservative versus enthusiastic modelling.

3. The N14 anti-afamin antibody Fab: a rare V_L1 CDR glycosylation, crystallographic re-sequencing, molecular plasticity and conservative versus enthusiastic modelling.